Skip to main content

INVESTIGANDO MECANISMOS COMUNES EN CANCER Y ENVEJECIMIENTO.

SAF2013-49082-P

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre FUNDACIO CENTRE DE REGULACIO GENOMICA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Detection of senescence markers during mammalian embryonic development

  • Storer, Mekayla, 1981-
  • Keyes, William M., 1973-
Senescence-associated β-galactosidase (SAβ-gal) is a convenient histological technique used to identify senescent cells. Its ease of use is helpful to initially screen and detect senescent cells in heterogeneous cell populations both in vitro and in vivo. However, SAβ-gal staining is not an unequivocal marker of the senescent state, and diagnosis of such usually requires additional markers demonstrating an absence of proliferation and expression of cell-cycle inhibitors. Nonetheless, SAβ-gal remains one of the most widely used biomarkers of senescent cells. Recently, by measuring SAβ-gal activity, the expression of the cyclin-dependent kinase inhibitor p21 (waf1/cip1) and demonstrating a lack of proliferation, we identified senescent cells in the developing embryo. This chapter describes the methods for identifying cellular senescence in the embryo, detailing protocols for the detection of SAβ-gal activity in both sections and at the whole mount level, and immunohistochemistry protocols for the detection of additional biomarkers of senescence., This work was funded by Grants SAF2010-18829 and SAF2013-49082-P to W.M.K. from the Spanish Ministry for Economy and Competitiveness, the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) from the Generalitat de Catalunya, and CRG core funding
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The senotherapeutic drug ABT-737 disrupts aberrant p21 expression to restore liver regeneration in adult mice

  • Ritschka, Birgit, 1985-
  • Knauer-Meyer, Tania
  • Sampaio Gonçalves, Daniel
  • Mas, Alba
  • Plassat, Jean-Luc
  • Durik, Matej
  • Jacobs, Hugues
  • Pedone, Elisa, 1985-
  • Di Vicino, Umberto
  • Cosma, Maria Pia, 1970-
  • Keyes, William M., 1973-
Young mammals possess a limited regenerative capacity in some tissues, which is lost upon maturation. We investigated whether cellular senescence might play a role in such loss during liver regeneration. We found that following partial hepatectomy, the senescence-associated genes p21, p16Ink4a, and p19Arf become dynamically expressed in different cell types when regenerative capacity decreases, but without a full senescent response. However, we show that treatment with a senescence-inhibiting drug improves regeneration, by disrupting aberrantly prolonged p21 expression. This work suggests that senescence may initially develop from heterogeneous cellular responses, and that senotherapeutic drugs might be useful in promoting organ regeneration., Work in the Keyes lab was funded in part by grants from the Spanish Ministry for Economy and Competitiveness (SAF2013-49082-P), La Fondation Recherche Medicale (FRM) (AJE20160635985), Fondation ARC (PJA20181208104), IDEX Attractivité-University of Strasbourg (IDEX2017), and La Fondation Schlumberger pour l'Education et la Recherche (FSER) (FSER 19-Year 2018), and ANR (ANR-19-CE13-0023-03). Work was also supported by grant ANR-10-LABX-0030-INRT, a French State fund managed by the Agence Nationale de la Recherche under the frame program Investissements d'Avenir (ANR-10-IDEX-0002-02)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration

  • Ritschka, Birgit, 1985-
  • Storer, Mekayla, 1981-
  • Mas Malavila, Alba
  • Heinzmann, Florian
  • Ortells Campos, Mª Carmen, 1984-
  • Morton, Jennifer P.
  • Sansom, Owen J.
  • Zender, Lars
  • Keyes, William M., 1973-
Senescence is a form of cell cycle arrest induced by stress such as DNA damage and oncogenes. However, while arrested, senescent cells secrete a variety of proteins collectively known as the senescence-associated secretory phenotype (SASP), which can reinforce the arrest and induce senescence in a paracrine manner. However, the SASP has also been shown to favor embryonic development, wound healing, and even tumor growth, suggesting more complex physiological roles than currently understood. Here we uncover timely new functions of the SASP in promoting a proregenerative response through the induction of cell plasticity and stemness. We show that primary mouse keratinocytes transiently exposed to the SASP exhibit increased expression of stem cell markers and regenerative capacity in vivo. However, prolonged exposure to the SASP causes a subsequent cell-intrinsic senescence arrest to counter the continued regenerative stimuli. Finally, by inducing senescence in single cells in vivo in the liver, we demonstrate that this activates tissue-specific expression of stem cell markers. Together, this work uncovers a primary and beneficial role for the SASP in promoting cell plasticity and tissue regeneration and introduces the concept that transient therapeutic delivery of senescent cells could be harnessed to drive tissue regeneration., We thank Ryan Driskell and Fiona Watt for technical advice, Guillaume Filion and Panagiotis Papasaikas for advice on statistics, Pura Muñoz-Cánoves for β-actin GFP mice, the Centre for Genomic Regulation Bioinformatics unit for assistance, and Pura Muñoz-Cánoves and Juan Valcarcel for critical reading of the manuscript. M.S. and B.R. were supported with fellowships from the “La Caixa” foundation. This work was funded by grants SAF2010-18829 and SAF2013-49082-P (to W.M.K.) from the Spanish Ministry for Economy and Competitiveness, the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) from the Generalitat de Catalunya, and Centre for Genomic Regulation core funding.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

ΔNp63α promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82

  • Di Giacomo, Valeria, 1983-
  • Tian, Tian V.
  • Mas Malavila, Alba
  • Pecoraro, Matteo, 1984-
  • Batlle-Morera, Laura
  • Noya Ferreiro, Lourdes
  • Martín Caballero, Juan
  • Ruberte, Jesús
  • Keyes, William M., 1973-
ΔNp63α is a critical mediator of epithelial development and stem cell function in a variety of tissues including the skin and breast, while overexpression of ΔNp63α acts as an oncogene to drive tumor formation and cancer stem cell properties in squamous cell carcinoma. However, with regards to the prostate, while ΔNp63α is expressed in the basal stem cells of the mature gland, during adenocarcinoma development, its expression is lost and its absence is used to clinically diagnose the malignant state. Surprisingly, here we identify a sub-population of bone metastatic prostate cancer cells in the PC3 cell line that express ΔNp63α. Interestingly, we discovered that ΔNp63α favors adhesion and stem-like growth of these cells in the bone microenvironment. In addition, we show that these properties require expression of the target gene CD82. Together, this work uncovers a population of bone metastatic prostate cancer cells that express ΔNp63α, and provides important information about the mechanisms of bone metastatic colonization. Finally, we identify metastasis-promoting properties for the tetraspanin family member CD82., We thank Roger Gomis and Marc Guiu for help with tumor imaging analysis, Jason Doles for help in the short hairpin design and the CRG Bioinformatics facility for assistance with microarray and sequencing data analysis. VDG was supported by a fellowship from ‘La Caixa’, and MP with an F.P.I. fellowship from the Spanish Ministry. This work was funded by Grants SAF2010-18829 (WMK) and SAF2013-49082-P (WMK) from the Ministerio de Economía y Competitividad and a Marie Curie International Reintegration Grant PIRG5-GA-2009-248262 (WMK).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The senotherapeutic drug ABT-737 disrupts aberrant p21 expression to restore liver regeneration in adult mice

  • Ritschka, Birgit, 1985-
  • Knauer-Meyer, Tania
  • Sampaio Gonçalves, Daniel
  • Mas, Alba
  • Plassat, Jean-Luc
  • Durik, Matej
  • Jacobs, Hugues
  • Pedone, Elisa, 1985-
  • Di Vicino, Umberto
  • Cosma, Maria Pia, 1970-
  • Keyes, William M., 1973-
Young mammals possess a limited regenerative capacity in some tissues, which is lost upon maturation. We investigated whether cellular senescence might play a role in such loss during liver regeneration. We found that following partial hepatectomy, the senescence-associated genes p21, p16Ink4a, and p19Arf become dynamically expressed in different cell types when regenerative capacity decreases, but without a full senescent response. However, we show that treatment with a senescence-inhibiting drug improves regeneration, by disrupting aberrantly prolonged p21 expression. This work suggests that senescence may initially develop from heterogeneous cellular responses, and that senotherapeutic drugs might be useful in promoting organ regeneration., Work in the Keyes lab was funded in part by grants from the Spanish Ministry for Economy and Competitiveness (SAF2013-49082-P), La Fondation Recherche Medicale (FRM) (AJE20160635985), Fondation ARC (PJA20181208104), IDEX Attractivité-University of Strasbourg (IDEX2017), and La Fondation Schlumberger pour l'Education et la Recherche (FSER) (FSER 19-Year 2018), and ANR (ANR-19-CE13-0023-03). Work was also supported by grant ANR-10-LABX-0030-INRT, a French State fund managed by the Agence Nationale de la Recherche under the frame program Investissements d'Avenir (ANR-10-IDEX-0002-02)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration

  • Ritschka, Birgit, 1985-
  • Storer, Mekayla, 1981-
  • Mas Malavila, Alba
  • Heinzmann, Florian
  • Ortells Campos, Mª Carmen, 1984-
  • Morton, Jennifer P.
  • Sansom, Owen J.
  • Zender, Lars
  • Keyes, William M., 1973-
Senescence is a form of cell cycle arrest induced by stress such as DNA damage and oncogenes. However, while arrested, senescent cells secrete a variety of proteins collectively known as the senescence-associated secretory phenotype (SASP), which can reinforce the arrest and induce senescence in a paracrine manner. However, the SASP has also been shown to favor embryonic development, wound healing, and even tumor growth, suggesting more complex physiological roles than currently understood. Here we uncover timely new functions of the SASP in promoting a proregenerative response through the induction of cell plasticity and stemness. We show that primary mouse keratinocytes transiently exposed to the SASP exhibit increased expression of stem cell markers and regenerative capacity in vivo. However, prolonged exposure to the SASP causes a subsequent cell-intrinsic senescence arrest to counter the continued regenerative stimuli. Finally, by inducing senescence in single cells in vivo in the liver, we demonstrate that this activates tissue-specific expression of stem cell markers. Together, this work uncovers a primary and beneficial role for the SASP in promoting cell plasticity and tissue regeneration and introduces the concept that transient therapeutic delivery of senescent cells could be harnessed to drive tissue regeneration., We thank Ryan Driskell and Fiona Watt for technical advice, Guillaume Filion and Panagiotis Papasaikas for advice on statistics, Pura Muñoz-Cánoves for β-actin GFP mice, the Centre for Genomic Regulation Bioinformatics unit for assistance, and Pura Muñoz-Cánoves and Juan Valcarcel for critical reading of the manuscript. M.S. and B.R. were supported with fellowships from the “La Caixa” foundation. This work was funded by grants SAF2010-18829 and SAF2013-49082-P (to W.M.K.) from the Spanish Ministry for Economy and Competitiveness, the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) from the Generalitat de Catalunya, and Centre for Genomic Regulation core funding.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

ΔNp63α promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82

  • Di Giacomo, Valeria, 1983-
  • Tian, Tian V.
  • Mas Malavila, Alba
  • Pecoraro, Matteo, 1984-
  • Batlle-Morera, Laura
  • Noya Ferreiro, Lourdes
  • Martín Caballero, Juan
  • Ruberte, Jesús
  • Keyes, William M., 1973-
ΔNp63α is a critical mediator of epithelial development and stem cell function in a variety of tissues including the skin and breast, while overexpression of ΔNp63α acts as an oncogene to drive tumor formation and cancer stem cell properties in squamous cell carcinoma. However, with regards to the prostate, while ΔNp63α is expressed in the basal stem cells of the mature gland, during adenocarcinoma development, its expression is lost and its absence is used to clinically diagnose the malignant state. Surprisingly, here we identify a sub-population of bone metastatic prostate cancer cells in the PC3 cell line that express ΔNp63α. Interestingly, we discovered that ΔNp63α favors adhesion and stem-like growth of these cells in the bone microenvironment. In addition, we show that these properties require expression of the target gene CD82. Together, this work uncovers a population of bone metastatic prostate cancer cells that express ΔNp63α, and provides important information about the mechanisms of bone metastatic colonization. Finally, we identify metastasis-promoting properties for the tetraspanin family member CD82., We thank Roger Gomis and Marc Guiu for help with tumor imaging analysis, Jason Doles for help in the short hairpin design and the CRG Bioinformatics facility for assistance with microarray and sequencing data analysis. VDG was supported by a fellowship from ‘La Caixa’, and MP with an F.P.I. fellowship from the Spanish Ministry. This work was funded by Grants SAF2010-18829 (WMK) and SAF2013-49082-P (WMK) from the Ministerio de Economía y Competitividad and a Marie Curie International Reintegration Grant PIRG5-GA-2009-248262 (WMK).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Detection of senescence markers during mammalian embryonic development

  • Storer, Mekayla, 1981-
  • Keyes, William M., 1973-
Senescence-associated β-galactosidase (SAβ-gal) is a convenient histological technique used to identify senescent cells. Its ease of use is helpful to initially screen and detect senescent cells in heterogeneous cell populations both in vitro and in vivo. However, SAβ-gal staining is not an unequivocal marker of the senescent state, and diagnosis of such usually requires additional markers demonstrating an absence of proliferation and expression of cell-cycle inhibitors. Nonetheless, SAβ-gal remains one of the most widely used biomarkers of senescent cells. Recently, by measuring SAβ-gal activity, the expression of the cyclin-dependent kinase inhibitor p21 (waf1/cip1) and demonstrating a lack of proliferation, we identified senescent cells in the developing embryo. This chapter describes the methods for identifying cellular senescence in the embryo, detailing protocols for the detection of SAβ-gal activity in both sections and at the whole mount level, and immunohistochemistry protocols for the detection of additional biomarkers of senescence., This work was funded by Grants SAF2010-18829 and SAF2013-49082-P to W.M.K. from the Spanish Ministry for Economy and Competitiveness, the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) from the Generalitat de Catalunya, and CRG core funding
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

ΔNp63α promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82

  • Di Giacomo, Valeria
  • Tian, Tian|||0000-0002-9906-0980
  • Mas, Alba
  • Pecoraro, Matteo
  • Batlle Morera, Laura|||0000-0002-6924-9002
  • Noya, Lorena
  • Martín-Caballero, Juan
  • Ruberte Paris, Jesús|||0000-0003-1540-1432
  • Keyes, W. M.
ΔNp63α is a critical mediator of epithelial development and stem cell function in a variety of tissues including the skin and breast, while overexpression of ΔNp63α acts as an oncogene to drive tumor formation and cancer stem cell properties in squamous cell carcinoma. However, with regards to the prostate, while ΔNp63α is expressed in the basal stem cells of the mature gland, during adenocarcinoma development, its expression is lost and its absence is used to clinically diagnose the malignant state. Surprisingly, here we identify a sub-population of bone metastatic prostate cancer cells in the PC3 cell line that express ΔNp63α. Interestingly, we discovered that ΔNp63α favors adhesion and stem-like growth of these cells in the bone microenvironment. In addition, we show that these properties require expression of the target gene CD82. Together, this work uncovers a population of bone metastatic prostate cancer cells that express ΔNp63α, and provides important information about the mechanisms of bone metastatic colonization. Finally, we identify metastasis-promoting properties for the tetraspanin family member CD82.